HNGE:NYSEHinge Health, Inc. Analysis
Data as of 2026-08-17 - not real-time
$88.49
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Hinge Health, Inc. is bullish at $88.49, with short-term averages leading the long-term ones. Across the trailing 30 sessions it gained 5.3%. Relative strength is 62.1 — approaching overbought — and the MACD signal is bullish. Watch $71.40 as support and $93.13 as the nearer resistance level.
Multiples put this in undervalued territory: 10.8 times earnings against the sector's 29.8. Analyst price targets sit 20.3% above the current price. Revenue is growing at 53.0% on a 15.1% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 51.5%, a beta of 1.13 and a maximum drawdown of 48.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 8 out of 10.
Multiples put this in undervalued territory: 10.8 times earnings against the sector's 29.8. Analyst price targets sit 20.3% above the current price. Revenue is growing at 53.0% on a 15.1% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 51.5%, a beta of 1.13 and a maximum drawdown of 48.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 8 out of 10.
Top Market Events
Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Small...12dHinge Health forecasts $856M-$860M 2026 revenue as it plans broader GI rollout in 2027Q2 2026 earnings call: revenue...Hinge Health Inc. HNGE saw its shares surge in the last session with trading volume being higher than average. The...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 53.51
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 10.8 versus sector average of 29.8
- Trading above the 200-day average of 53.51
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- P/E of 10.8 versus sector average of 29.8
- Analyst targets imply +20.3% versus the current price
- Profit margin of 15.1% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth53.00%
Profit Margin15.15%
P/E Ratio10.8
ROE30.38%
ROA7.70%
Debt/Equity1.71
P/B Ratio20.6
Op. Cash Flow$290.8M
Free Cash Flow$299.6M
Industry P/E29.8
Technical Analysis
TrendBullish
RSI62.1
Support$71.40
Resistance$93.13
MA 20$81.32
MA 50$78.48
MA 200$53.51
MACDBullish
VolumeIncreasing
Fear & Greed Index94.75
Valuation
Fair Value$135.62
Target Price$106.47
Upside/Downside20.31%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.13
Volatility51.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.